Ovarian Cancer

Study ties breast gene to high-risk uterine cancer

Women with a faulty breast cancer gene might face a greater chance of rare but deadly uterine tumors despite having their ovaries removed to lower their main cancer risks, doctors are reporting.

Mar 24, 2014
popularity not rated yet | comments 0

For women's cancers, where you're treated matters

(HealthDay)—Where you're treated for ovarian or other gynecologic cancers makes a difference. Women with these conditions live more than a year longer on average if they're treated at hospitals that deal ...

Mar 24, 2014
popularity 5 / 5 (1) | comments 0

US tells 23andMe to halt sales of genetic test

The U.S. Food and Drug Administration is ordering genetic test maker 23andMe to halt sales of its personalized DNA test kits, saying the company has failed to show that the technology is backed by science.

Nov 25, 2013
popularity 4.8 / 5 (5) | comments 0

BRCAPRO model underestimates BRCA1/2 mutation risk

(HealthDay)—Use of the BRCAPRO model for assessment of the likelihood of having a germline BRCA1/BRCA2 mutation, based on age, ethnicity, and family history, may underestimate the risk of mutations, ac ...

Mar 21, 2014
popularity not rated yet | comments 0

The only top 10 cancer where survival rates are falling

Of the top 10 cancers in the UK, bladder cancer is only one where survival rates have been shown to be getting worse. New figures published this month in the Journal of Clinical Urology confirm in a study of cases of bla ...

Feb 25, 2014
popularity 4.5 / 5 (35) | comments 0

Latest Spotlight News